Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia

Head and Neck

Volumn 22, Issue 7, 2000, Pages 658-661

  Gonzalez Moles, Miguel A ^a   Ruiz Avila, Isabel ^a   Rodriguez Archilla, Alberto ^a   Martinez Lara, Ildefonso ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Ki 67 antigen; Oral epithelial dysplasia

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; ENZYME IMMUNOASSAY; EPITHELIUM; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PRECANCER; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 0034292859     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0347(200010)22:7<658::AID-HED3>3.0.CO;2-A     Document Type: Article

References (16)

1. Shin DM, Voravud N, Ro JY, Lee JS, Hong WK, Hittelman WN. Sequential increase in proliferating cell nuclear antigen expression in head and neck tumorigenesis, a potential biomarker. J Natl Cancer Inst 1993;12:971-978.
2. Huber MH, Lippman SM, Hong WK. Chemoprevention of head and neck cancer. Semin Oncol 1994;21:366-375.
3. Coltrera MD, Zarbo RJ, Sakr WA, Gown AM. Markers for dysplasia of the upper aerodigestive tract. Suprabasul expression of PCNA, p53 and CK19 in alcohol-fixed embedded tissue. Am J Pathol 1992;141:817-825.
4. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 1989;134:733-739.
5. Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990; 162:285-294.
6. Tsai ST, Jin YT. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinomas. J Oral Pathol Med 1995;24:313-315.
7. Hong MK, Laskin WB, Herman BE, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 1995;75: 423-429.
8. Krutchkoff DJ, Eisenberg E, Anderson C. Dysplasia of oral mucosa: a unified approach to proper evaluation. Mod Pathol 1991;4:113-119.
9. Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK. Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 1990;82: 555-560.
10. Seight PM, Organ PR. The natural history and pathology of oral cancer and precancer. Commun Dental Health 1993;10:31-41.
11. Kushner J, Bradley G, Jordan RC. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth. J Pathol 1997;183:418-423.
12. Zoeller J, Flentje M, Sinn P, Born IA. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas. Anal Cell Pathol 1994;7: 77-88.
13. Saito T, Nakajima T, Mogi K. Immunohistochemical analysis of cell cycle-associated proteins p16. pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med 1999;28:226-232.
14. Zidar N, Gale N, Cor A, Kambic V. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx. J Laryngol Otol 1996;110:440-445.
15. Martinez-Lara I. Gonzalez-Moles MA, Ruiz-Avila I, Bravo M, Ramos MC, Fernandez-Martinez JA. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa. Acta Stomatol Belg 1996;93:29-32.
16. van Oijen MGCT, Gilsing MMA, Rijksen G, Hordijk GJ, Slootweg PJ. Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol 1998;34:297-303.